Hogan Lovells has advised Ares in relation to the unitranche facilities provided to BC Partners for the acquisition of a majority stake in Synthon International Holding B.V., a global market leader in the development of complex Generics, from its parent company Synthon Holding B.V.

BC Partners will partner with Synthon’s founder Dr. Jacques Lemmens, who will remain a shareholder in the Company. The Company will be carved out from the Parent and continue to operate under the Synthon brand. The transaction is subject to regulatory approvals and is expected to close in the coming months.

This is the second transaction in which we have advised Ares on deals with BC Partners; in 2018 we advised Ares Management in relation to the unitranche and PIK facilities provided for the acquisition of VetPartners by BC Partners and the refinancing of the VetPartners Group.

The Hogan Lovells team was led by Partners Jo Robinson and Wouter Jongen.